Molecular epidemiology of hepatitis C virus in a social network of injection drug users

Journal of Infectious Diseases

Volumn 190, Issue 9, 2004, Pages 1586-1595

  Aitken, Campbell K ^a   McCaw, Rhonda F ^b   Bowden, D Scott ^b   Tracy, Samantha L ^b   Kelsall, Jenny G ^a   Higgs, Peter G ^a   Kerger, Michael J ^a   Nguyen, Hoang ^a   Crofts, J Nick ^a  

^a BURNET INSTITUTE   (Australia)

^b VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC RNA; VIRUS PROTEIN;

ARTICLE; AUSTRALIA; COHORT ANALYSIS; CONTROLLED STUDY; GENE CLUSTER; GENE SEQUENCE; GENETIC DISTANCE; GENETIC IDENTIFICATION; GENOME ANALYSIS; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTRAVENOUS DRUG ABUSE; MOLECULAR PHYLOGENY; PRIORITY JOURNAL; PROTEIN STRUCTURE; SEQUENCE ANALYSIS; SOCIAL ASPECT; VIRAL GENETICS; VIRUS DETECTION; VIRUS GENOME; VIRUS TRANSMISSION;

AUSTRALIA; COHORT STUDIES; DNA, COMPLEMENTARY; EPIDEMIOLOGY, MOLECULAR; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; PHYLOGENY; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY; SOCIAL SUPPORT; SUBSTANCE ABUSE, INTRAVENOUS; VIRAL CORE PROTEINS; VIRAL NONSTRUCTURAL PROTEINS; VIREMIA;

EID: 6944219957     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/424678     Document Type: Article

References (29)

1. Kim YB, Cho YK. Monophyletic clade of HIV-1 subtype B in Korea: evolutionary pressure or single introduction? AIDS Res Hum Retroviruses 2003; 19:619-23.
2. Yoshii E, Shinzawa H, Saito T, et al. Molecular epidemiology of hepatitis C virus infection in an area endemic for community-acquired acute hepatitis C. Tohoku J Exp Med 1999; 188:311-6.
3. Ndjomou J, Pybus OG, Matz B. Phylogenetic analysis of hepatitis C virus isolates indicates a unique pattern of endemic infection in Cameroon. J Gen Virol 2003; 84:2333-41.
4. Paraskevis D, Lemey P, Salemi M, Suchard M, Van De Peer Y, Vandamme AM. Analysis of the evolutionary relationships of HIV-1 and SIVcpz sequences using Bayesian inference: implications for the origin of HIV-1. Mol Biol Evol 2003; 20:1986-96.
5. Cochrane A, Searle B, Hardie A, et al. A genetic analysis of hepatitis C virus transmission between injection drug users. J Infect Dis 2002; 186:1212-21.
6. Baskar PV, Ray SC, Rao R, Quinn TC, Hildreth JE, Bollinger RC. Presence in India of HIV type 1 similar to North American strains. AIDS Res Hum Retroviruses 1994; 10:1039-41.
7. Gonzalez-Candelas F, Bracho MA, Moya A. Molecular epidemiology and forensic genetics: application to a hepatitis C virus transmission event at a hemodialysis unit. J Infect Dis 2003; 187:352-8.
8. Visco-Comandini U, Cappiello G, Liuzzi G, et al. Monophyletic HIV type 1 CRF02-AG in a nosocomial outbreak in Benghazi, Libya. AIDS Res Hum Retroviruses 2002; 18:727-32.
9. Birch CJ, McCaw RF, Bulach DM, et al. Molecular analysis of human immunodeficiency virus strains associated with a case of criminal transmission of the virus. J Infect Dis 2000; 182:941-4.
10. Allender T, Gruber A, Nagahvi M, et al. Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward. Lancet 1995; 345:603-7.
11. Latkin C, Mandell W, Oziemkowska M, et al. Using social network analysis to study patterns of drug use among urban dwellers at high risk for HIV/AIDS. Drug Alcohol Depend 1995; 38:1-9.
12. Laumann EO, Youm Y. Racial/ethnic group differences in the prevalence of sexually transmitted diseases in the United States: a network explanation. Sex Transm Dis 1999; 26:250-61.
13. Morris M, Zavisca J, Dean L. Social and sexual networks: their role in the spread of HIV/AIDS among young gay men. AIDS Educ Prev 1995; 7(Suppl 5):24-35.
14. Friedman SR, Kottiri BJ, Neaigus A, Curtis R, Vermund SH, Des Jarlais DC. Network-related mechanisms may help explain long-term HIV-1 seroprevalence levels that remain high but do not approach population-group saturation. Am J Epidemiol 2000; 152:913-22.
15. Rothenberg R, Baldwin J, Trotter R, Muth SQ. The risk environment for HIV transmission: results from the Atlanta and Flagstaff network studies. J Urban Health 2001; 78:419-32.
16. Australian Bureau of Statistics. 2001 census of population and housing. Available at: http://www.abs.gov.au/Ausstats/abs@census.nsf/ddc9b4f92 657325cca256c3e000bdbaf/0f0a516f6bfc8b62ca256bbf00005433! OpenDocument#CensusCounts. Accessed 6 February 2004.
17. McCaw R, Moaven L, Locarnini S, Bowden S. Hepatitis C virus genotypes in Australia. J Viral Hepat 1997; 4:351-7.
18. Dev A, McCaw R, Sundararajan V, Bowden S, Sievert W. Southeast Asian patients with chronic hepatitis C: the impact of novel genotypes and race on treatment outcome. Hepatology 2002; 36:1259-65.
19. Feldenstein J. PHYLIP: phylogenetic inference package. Version 3.572. Seattle: Department of Genetics, University of Washington, 1993.
20. Hershkovitz MA, Leipe DD. Phylogenetic analysis. In: Baxevanis AD, Ouellette BFF, eds. Bioinformatics: a practical guide to the analysis of genes and proteins. Toronto: John Wiley, 1998.
21. Tallis G, Ryan G, Lambert S, et al. Evidence of patient-to-patient transmission of hepatitis C virus through contaminated intravenous anaesthetic ampoules. J Viral Hepat 2003; 10:234-9.
22. Borgatti SP, Everett MG, Freeman LC. UCINET 5.0. Version 1.00. Natick, MA: Analytic Technologies, 1999.
23. Potterat JJ, Phillips-Plummer L, Muth SQ, et al. Risk network structure in the early epidemic phase of HIV transmission in Colorado Springs. Sex Transm Infect 2002; 78(Suppl 1):i159-63.
24. Rothenberg RB, Potterat JJ, Woodhouse DE, Muth SQ, Darrow WW, Klovdahl AS. Social network dynamics and HIV transmission. AIDS 1998; 12:1529-36.
25. Friedman SR, Neagius A, Jose B, et al. Sociometric risk networks and risk for HIV infection. Am J Pub Health 1997; 87:1289-96.
26. Dore GJ, Law M, MacDonald M, Kaldor JM. Epidemiology of hepatitis C virus infection in Australia. J Clin Virol 2003; 26:171-84.
27. Hu YW, Balaskas E, Furione M, et al. Comparison and application of a novel genotyping method, semiautomated primer-specific and mispair extension analysis, and four other genotyping assays for detection of hepatitis C virus mixed-genotype infections. J Clin Microbiol 2000; 38:2807-13.
28. Giannini C, Giannelli F, Monti M, et al. Prevalence of mixed infection by different hepatitis C virus genotypes in patients with hepatitis C virus-related chronic liver disease. J Lab Clin Med 1999; 134:68-73.
29. Mehta SH, Cox A, Hoover DR, et al. Protection against persistence of hepatitis C. Lancet 2002; 359:1478-83.